Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses (Q64381342)

1

0 references

S Chada

2

0 references

M Stipanov

3

0 references

S Nadaf

4

0 references

F I Ciernik

5

0 references

D I Gabrilovich

6

0 references

D P Carbone

Clinical and Experimental Immunology

7

0 references

language of work or name

English

0 references

publication date

August 1999

0 references

published in

0 references

volume

117

0 references

issue

2

0 references

page(s)

244-51

0 references

cites work

The dendritic cell system and its role in immunogenicity

1 reference

12 December 2020

High efficiency adenovirus-mediated gene transfer to human dendritic cells

1 reference

12 December 2020

A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells

1 reference

12 December 2020

Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells.

1 reference

12 December 2020

p53, a potential target for tumor-directed T cells

1 reference

12 December 2020

Use of recombinant adenovirus for metabolic engineering of mammalian cells.

1 reference

12 December 2020

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design

1 reference

12 December 2020

Mutant Oncopeptide Immunization Induces CTL Specifically Lysing Tumor Cells Endogenously Expressing the Corresponding Intact Mutant p53

1 reference

12 December 2020

Targeting p53 as a general tumor antigen

1 reference

12 December 2020

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

12 December 2020

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts

1 reference

12 December 2020

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

1 reference

12 December 2020

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

12 December 2020

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

1 reference

12 December 2020

Peptide-based cancer vaccines

1 reference

12 December 2020

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

1 reference

12 December 2020

Gene therapy for cancer: what have we done and where are we going?

1 reference

12 December 2020

Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL.

1 reference

12 December 2020

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

1 reference

12 December 2020

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

1 reference

12 December 2020

Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation

1 reference

12 December 2020